U.S. plans to reclassify marijuana from Schedule I to III could ease taxes and research limits, offering relief to cannabis firms but leaving key federal restrictions intact.
U.S. plans to reclassify marijuana could ease taxes, expand banking access and boost investment for cannabis companies, though regulatory hurdles and state-federal conflicts may persist.